Nektar Therapeutics
US ˙ NasdaqCM ˙ GB00BPJHV584

SecurityNKTR / Nektar Therapeutics
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership5,722 shares
Latest Disclosed Value $ 411,697
Simplex Trading, Llc ownership in NKTR / Nektar Therapeutics

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 5,722 shares of Nektar Therapeutics (US:NKTR) valued at $411,698 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 21,936 shares of Nektar Therapeutics. This represents a change in shares of -73.92% during the quarter. The current value of the position is $338,914 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (NKTR) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NKTR / Nektar Therapeutics Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NEKTAR THERAPEUTICS COM 640268306 5,722 -16,214 -73.92 412 -55.66 0.0001
2026-02-11 2025-12-31 13F NEKTAR THERAPEUTICS COM 640268306 21,936 -54,514 -71.31 927 23,075.00 0.0005
2025-11-12 2025-09-30 13F NEKTAR THERAPEUTICS COM 640268306 76,450 29,497 62.82 4 300.00 0.0022
2025-08-05 2025-06-30 13F NEKTAR THERAPEUTICS COM 640268306 46,953 46,953 1 0.0007
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-05 2025-06-30 13F NEKTAR THERAPEUTICS CALL Call 0 -100.00 0 n/a n/a n/a
2025-05-12 2025-03-31 13F NEKTAR THERAPEUTICS CALL Call 1,500 -90.80 0 n/a n/a n/a
2025-02-11 2024-12-31 13F NEKTAR THERAPEUTICS CALL Call 16,300 -66.73 0 n/a n/a n/a
2024-11-08 2024-09-30 13F NEKTAR THERAPEUTICS CALL Call 49,000 536.36 0 n/a n/a n/a
2024-07-25 2024-06-30 13F NEKTAR THERAPEUTICS CALL Call 7,700 -96.01 0 n/a n/a n/a
2024-04-25 2024-03-31 13F NEKTAR THERAPEUTICS CALL Call 193,200 193,100.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F NEKTAR THERAPEUTICS CALL Call 100 -98.39 0 n/a n/a n/a
2023-11-01 2023-09-30 13F NEKTAR THERAPEUTICS CALL Call 6,200 29.17 0 n/a n/a n/a
2023-08-04 2023-06-30 13F NEKTAR THERAPEUTICS CALL Call 4,800 33.33 0 n/a n/a n/a
2023-04-27 2023-03-31 13F NEKTAR THERAPEUTICS CALL Call 3,600 -57.14 0 n/a n/a n/a
2023-02-02 2022-12-31 13F NEKTAR THERAPEUTICS CALL Call 8,400 -96.29 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F NEKTAR THERAPEUTICS CALL Call 226,400 -7.78 724 -22.32 n/a n/a n/a
2022-08-03 2022-06-30 13F NEKTAR THERAPEUTICS CALL Call 245,500 151.28 932 77.19 n/a n/a n/a
2022-05-02 2022-03-31 13F NEKTAR THERAPEUTICS CALL Call 97,700 103.54 526 -18.83 n/a n/a n/a
2022-02-23 2021-12-31 13F/A NEKTAR THERAPEUTICS CALL Call 48,000 310.26 648 217.65 n/a n/a n/a
2022-02-04 2021-12-31 13F NEKTAR THERAPEUTICS CALL Call 11,700 204 n/a n/a n/a
2021-10-28 2021-09-30 13F NEKTAR THERAPEUTICS CALL Call 11,700 5.41 204 7.37 n/a n/a n/a
2021-08-12 2021-06-30 13F NEKTAR THERAPEUTICS CALL Call 11,100 3,740.83 190 -67.13 n/a n/a n/a
2021-04-26 2021-03-31 13F NEKTAR THERAPEUTICS CALL Call 289 -69.39 578 -63.97 n/a n/a n/a
2021-02-02 2020-12-31 13F NEKTAR THERAPEUTICS CALL Call 944 198.73 1,604 206.11 n/a n/a n/a
2020-10-14 2020-09-30 13F NEKTAR THERAPEUTICS CALL Call 316 -15.96 524 -39.77 n/a n/a n/a
2020-07-13 2020-06-30 13F NEKTAR THERAPEUTICS CALL Call 376 596.30 870 806.25 n/a n/a n/a
2020-04-29 2020-03-31 13F NEKTAR THERAPEUTICS CALL Call 54 -93.01 96 -94.24 n/a n/a n/a
2020-02-05 2019-12-31 13F NEKTAR THERAPEUTICS CALL Call 772 -42.98 1,666 -32.44 n/a n/a n/a
2019-10-15 2019-09-30 13F NEKTAR THERAPEUTICS CALL Call 1,354 177.46 2,466 42.05 n/a n/a n/a
2019-07-26 2019-06-30 13F NEKTAR THERAPEUTICS CALL Call 488 -3.56 1,736 2.12 n/a n/a n/a
2019-04-18 2019-03-31 13F NEKTAR THERAPEUTICS CALL Call 506 25.87 1,700 28.69 n/a n/a n/a
2019-01-16 2018-12-31 13F NEKTAR THERAPEUTICS CALL Call 402 58.89 1,321 -14.33 n/a n/a n/a
2018-10-23 2018-09-30 13F NEKTAR THERAPEUTICS CALL Call 253 -63.49 1,542 -54.42 n/a n/a n/a
2018-07-30 2018-06-30 13F NEKTAR THERAPEUTICS CALL Call 693 497.41 3,383 723.11 n/a n/a n/a
2018-04-26 2018-03-31 13F NEKTAR THERAPEUTICS CALL Call 116 -76.71 411 -72.51 n/a n/a n/a
2018-01-10 2017-12-31 13F NEKTAR THERAPEUTICS CALL Call 498 277.27 1,495 5,239.29 n/a n/a n/a
2017-10-25 2017-09-30 13F NEKTAR THERAPEUTICS CALL Call 132 -66.67 28 27.27 n/a n/a n/a
2017-07-12 2017-06-30 13F NEKTAR THERAPEUTICS CALL Call 396 -38.32 22 -95.54 n/a n/a n/a
2017-04-21 2017-03-31 13F NEKTAR THERAPEUTICS CALL Call 642 817.14 493 9,760.00 n/a n/a n/a
2017-01-11 2016-12-31 13F NEKTAR THERAPEUTICS CALL Call 70 18.64 5 25.00 n/a n/a n/a
2016-10-07 2016-09-30 13F NEKTAR THERAPEUTICS CALL Call 59 -45.87 4 33.33 n/a n/a n/a
2016-07-18 2016-06-30 13F NEKTAR THERAPEUTICS CALL Call 109 505.56 3 50.00 n/a n/a n/a
2016-04-14 2016-03-31 13F NEKTAR THERAPEUTICS CALL Call 18 -92.41 2 -98.06 n/a n/a n/a
2016-01-20 2015-12-31 13F NEKTAR THERAPEUTICS CALL Call 237 478.05 103 5,050.00 n/a n/a n/a
2015-10-08 2015-09-30 13F NEKTAR THERAPEUTICS CALL Call 41 -78.76 0 -100.00 n/a n/a n/a
2015-07-08 2015-06-30 13F NEKTAR THERAPEUTICS CALL Call 193 135.37 12 1,100.00 n/a n/a n/a
2015-04-21 2015-03-31 13F NEKTAR THERAPEUTICS CALL Call 82 20.59 1 -92.31 n/a n/a n/a
2015-03-04 2014-12-31 13F NEKTAR THERAPEUTICS CALL Call 68 13 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-05 2025-06-30 13F NEKTAR THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2025-05-12 2025-03-31 13F NEKTAR THERAPEUTICS PUT Put 84,200 0 n/a n/a n/a
2025-02-11 2024-12-31 13F NEKTAR THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2024-11-08 2024-09-30 13F NEKTAR THERAPEUTICS PUT Put 3,900 -36.07 0 n/a n/a n/a
2024-07-25 2024-06-30 13F NEKTAR THERAPEUTICS PUT Put 6,100 22.00 0 n/a n/a n/a
2024-04-25 2024-03-31 13F NEKTAR THERAPEUTICS PUT Put 5,000 0 n/a n/a n/a
2024-02-02 2023-12-31 13F NEKTAR THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2023-11-01 2023-09-30 13F NEKTAR THERAPEUTICS PUT Put 14,800 6.47 0 n/a n/a n/a
2023-08-04 2023-06-30 13F NEKTAR THERAPEUTICS PUT Put 13,900 0 n/a n/a n/a
2023-04-27 2023-03-31 13F NEKTAR THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2023-02-02 2022-12-31 13F NEKTAR THERAPEUTICS PUT Put 5,000 -58.33 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F NEKTAR THERAPEUTICS PUT Put 12,000 -62.50 38 -68.60 n/a n/a n/a
2022-08-03 2022-06-30 13F NEKTAR THERAPEUTICS PUT Put 32,000 -95.76 121 -97.02 n/a n/a n/a
2022-05-02 2022-03-31 13F NEKTAR THERAPEUTICS PUT Put 754,700 2,511.42 4,067 942.82 n/a n/a n/a
2022-02-23 2021-12-31 13F/A NEKTAR THERAPEUTICS PUT Put 28,900 67.05 390 28.71 n/a n/a n/a
2022-02-04 2021-12-31 13F NEKTAR THERAPEUTICS PUT Put 17,300 303 n/a n/a n/a
2021-10-28 2021-09-30 13F NEKTAR THERAPEUTICS PUT Put 17,300 0.00 303 2.36 n/a n/a n/a
2021-08-12 2021-06-30 13F NEKTAR THERAPEUTICS PUT Put 17,300 13,965.04 296 20.33 n/a n/a n/a
2021-04-26 2021-03-31 13F NEKTAR THERAPEUTICS PUT Put 123 -76.79 246 -72.70 n/a n/a n/a
2021-02-02 2020-12-31 13F NEKTAR THERAPEUTICS PUT Put 530 -23.96 901 -22.06 n/a n/a n/a
2020-10-14 2020-09-30 13F NEKTAR THERAPEUTICS PUT Put 697 -1.97 1,156 -29.77 n/a n/a n/a
2020-07-13 2020-06-30 13F NEKTAR THERAPEUTICS PUT Put 711 -5.95 1,646 22.02 n/a n/a n/a
2020-04-29 2020-03-31 13F NEKTAR THERAPEUTICS PUT Put 756 -30.58 1,349 -42.60 n/a n/a n/a
2020-02-05 2019-12-31 13F NEKTAR THERAPEUTICS PUT Put 1,089 -25.82 2,350 -12.08 n/a n/a n/a
2019-10-15 2019-09-30 13F NEKTAR THERAPEUTICS PUT Put 1,468 116.84 2,673 11.00 n/a n/a n/a
2019-07-26 2019-06-30 13F NEKTAR THERAPEUTICS PUT Put 677 23.99 2,408 31.30 n/a n/a n/a
2019-04-18 2019-03-31 13F NEKTAR THERAPEUTICS PUT Put 546 102.22 1,834 106.76 n/a n/a n/a
2019-01-16 2018-12-31 13F NEKTAR THERAPEUTICS PUT Put 270 -59.52 887 -78.18 n/a n/a n/a
2018-10-23 2018-09-30 13F NEKTAR THERAPEUTICS PUT Put 667 -6.19 4,066 17.14 n/a n/a n/a
2018-07-30 2018-06-30 13F NEKTAR THERAPEUTICS PUT Put 711 625.51 3,471 6,705.88 n/a n/a n/a
2018-04-26 2018-03-31 13F NEKTAR THERAPEUTICS PUT Put 98 -80.59 51 27.50 n/a n/a n/a
2018-01-10 2017-12-31 13F NEKTAR THERAPEUTICS PUT Put 505 193.60 40 344.44 n/a n/a n/a
2017-10-25 2017-09-30 13F NEKTAR THERAPEUTICS PUT Put 172 -58.75 9 -43.75 n/a n/a n/a
2017-07-12 2017-06-30 13F NEKTAR THERAPEUTICS PUT Put 417 -48.77 16 23.08 n/a n/a n/a
2017-04-21 2017-03-31 13F NEKTAR THERAPEUTICS PUT Put 814 81.70 13 -72.92 n/a n/a n/a
2017-01-11 2016-12-31 13F NEKTAR THERAPEUTICS PUT Put 448 460.00 48 433.33 n/a n/a n/a
2016-10-07 2016-09-30 13F NEKTAR THERAPEUTICS PUT Put 80 17.65 9 350.00 n/a n/a n/a
2016-07-18 2016-06-30 13F NEKTAR THERAPEUTICS PUT Put 68 61.90 2 0.00 n/a n/a n/a
2016-04-14 2016-03-31 13F NEKTAR THERAPEUTICS PUT Put 42 -23.64 2 0.00 n/a n/a n/a
2016-01-20 2015-12-31 13F NEKTAR THERAPEUTICS PUT Put 55 -9.84 0 -100.00 n/a n/a n/a
2015-10-08 2015-09-30 13F NEKTAR THERAPEUTICS PUT Put 61 -4.69 3 50.00 n/a n/a n/a
2015-07-08 2015-06-30 13F NEKTAR THERAPEUTICS PUT Put 64 -55.24 2 -88.24 n/a n/a n/a
2015-04-21 2015-03-31 13F NEKTAR THERAPEUTICS PUT Put 143 -44.57 17 -41.38 n/a n/a n/a
2015-03-04 2014-12-31 13F NEKTAR THERAPEUTICS PUT Put 258 29 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.